Medical
Light Therapy Through MedicLight's Blood Irradiation
Numerous
low level laser therapy ("LLLT") studies provide
positive evidence on LLLT as a successful method to
treat a number of diseases. It is also tested over many
years as a successful method for pain management. Our
own tests through blood irradiation have been pointing
towards the conclusion that it can at least deal with
diseases and health disorders related to impaired blood
circulation caused by high red blood cell aggregation.
The
greater body of scientific literature discusses the
response of normal tissue cells, not red blood cells
("RBCs") when explaining the mechanisms of
LLLT. Normal tissue cells have mitochondria that respond
to the light and subsequently get “bio-stimulated”.
The RBCs do not have mitochondria and they constitute
95 percent of cells in the blood. Much of the rest of
the blood consist of plasma. Some literature suggests
that notwithstanding, RBCs do react by stimulating the
release of ATP. Something else is also happening that
results in the benefits that we are witnessing.
It
has been found that red light actually inhibits the
kind of RBC aggregation we see in the figure below.
The picture below is a 40x microscopy magnification
of a blood sample taken from the subject before he was
treated with the device.
|
Blood
sample before the 25-minute treatment |
There
is much evidence of RBC aggregation in this sample,
which is an indication of a health disorder. After a
25 minute treatment of light therapy delivered with
MedicLight's system to the same subject, the next blood
sample looks completely different, also magnified at
40x.
|
Blood
sample after the 25-minute treatment |
There
is no longer any sign of RBC aggregation, and without
the aggregation, the blood flows much better, resulting
in improved systemic blood circulation.
We
do not claim that the MedicLight's method of delivering
light therapy to the nasal cavity is more effective
than the original Russian system of intravenous blood
irradiation in improving blood rheology. Evidence points
to the same level of effectiveness. But it is clear
that it is more user friendly and more convenient by
a large order of magnitude - non-invasive, portable
and can be self-administered - all the elements that
make it a game-changing proposition.
Some
researchers argue that it does not matter if the red
light is transmitted by low level laser diode or red
light emitting diode (LED). The MedicLights device applies
red low level laser light of 655nm to achieve the results.
This means that if we want to avoid RBC aggregation,
just shine red light on to the blood system (at the
right dosage). We simply do it more conveniently than
any other way.
Whatever
is happening must be taking place beyond the RBC response.
That is because not only are the RBCs disaggregated,
there is evidence of healing beyond the reach of RBCs
judging by publshed evidence related to diseases such
as diabetes and high cholesterol.
The
heart of it all
The
picture below, taken through a “darkfield”
microscope offers a clearer visual reference profile
of a healthy blood sample. The RBCs show no deformity,
with 2 white blood cells (in the right proportion to
the number of RBCs) in clear plasma.
|
Reference
blood sample observed through a "darkfield"
microscope |
A
blood sample like that above is a joy to see –
mainly because you know that the owner of a blood sample
like this in all probability has no serious health issue.
Visually, it is easier to imagine that the RBCs with
the plasma in this sample are much better able to do
their job of transporting oxygen and nutrients to tissues
throughout the body.
Because
many of our blood capillaries are small, we can hypothesise
that we need RBCs that are separated from each other
to have optimal flow. Small blood capillaries comprise
99 percent of the body blood vessels, the smallest,
being wide enough only for single RBCs to flow through,
as illustrated in the figure below, or even narrower
so that the RBCs have to deform themselves to flow through
the micro-vascular channels.
|
Illustration
of RBC's in a micro capillary.
Source:
National Museum of Health and Medicine, Washington
DC |
Studies
on blood circulation in small blood capillaries support
the notion that elevating red cell aggregation can reduce
blood flow in these vessels to varying degrees .
The
combination of various factors to give good blood flow
properties are therefore important for nutrient and
oxygen transportation throughout the body. It is a complex
subject and is mainly determined by key variables such
as blood viscosity, RBC mass (hematocrit), RBC aggregation,
deformability and dilatation quality of the vessel walls.
With
this knowledge, it is not surprising to learn that there
are studies showing the correlation between high blood
pressure (BP) or hypertension with high viscosity in
the blood, particularly in more elderly subjects. If
we assume that the vascular walls are unable to dilate,
thicker and slow moving blood can only exert more pressure
on the these walls. This is the basic concept behind
poor blood rheology as a major cause for high BP.
In
summary, it is important to know of the presence of
RBC aggregation because it affects blood flow directly
by its obstructive nature and indirectly, through its
impact on viscosity.
Back
to the top
|
